Detalles de la búsqueda
1.
Acetylcholine and noradrenaline enhance foraging optimality in humans.
Proc Natl Acad Sci U S A
; 120(36): e2305596120, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37639601
2.
Persistent binding at dopamine transporters determines sustained psychostimulant effects.
Proc Natl Acad Sci U S A
; 120(6): e2114204120, 2023 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36730201
3.
Examining the role of dopamine in methylphenidate's effects on resting brain function.
Proc Natl Acad Sci U S A
; 120(52): e2314596120, 2023 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109535
4.
Methylphenidate as a causal test of translational and basic neural coding hypotheses.
Proc Natl Acad Sci U S A
; 119(17): e2120529119, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467980
5.
Interactions of catecholamines and GABA+ in cognitive control: Insights from EEG and 1H-MRS.
Neuroimage
; 293: 120619, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38679186
6.
Phasic dopamine signals are reduced in the spontaneously hypertensive rat and increased by methylphenidate.
Eur J Neurosci
; 59(7): 1567-1584, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38314648
7.
Development of a novel rodent rapid serial visual presentation task reveals dissociable effects of stimulant versus nonstimulant treatments on attentional processes.
Cogn Affect Behav Neurosci
; 24(2): 351-367, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253774
8.
The Ability to Voluntarily Regulate Theta Band Activity Affects How Pharmacological Manipulation of the Catecholaminergic System Impacts Cognitive Control.
Int J Neuropsychopharmacol
; 27(1)2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181228
9.
Effects of Catecholaminergic and Transcranial Direct Current Stimulation on Response Inhibition.
Int J Neuropsychopharmacol
; 27(6)2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38742426
10.
Treatment with psychostimulants and atomoxetine in people with psychotic disorders: reassessing the risk of clinical deterioration in a real-world setting.
Br J Psychiatry
; 224(3): 98-105, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38044665
11.
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series.
J Clin Psychopharmacol
; 44(1): 35-38, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37851403
12.
In utero exposure to ADHD medication and long-term offspring outcomes.
Mol Psychiatry
; 28(4): 1739-1746, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759544
13.
Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.
Bipolar Disord
; 26(3): 216-239, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38433530
14.
Graph analysis uncovers an opposing impact of methylphenidate on connectivity patterns within default mode network sub-divisions.
Behav Brain Funct
; 20(1): 15, 2024 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38902791
15.
Attention-deficit/hyperactivity disorder in pregnancy and the postpartum period.
Am J Obstet Gynecol
; 231(1): 19-35, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38432409
16.
Exploring the Relationship between Adherence to Therapy, Treatment Acceptability, and Clinical Outcomes in Adults with Attention-Deficit/Hyperactivity Disorder: Results from the COMPAS Multicenter Randomized Controlled Trial.
Psychother Psychosom
; 93(1): 46-64, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38142690
17.
Methylphenidate for treating fatigue in palliative cancer care - effect and side effects in real-world data from a palliative care unit.
Acta Oncol
; 63: 9-16, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38348853
18.
Impaired monoamine neural system in the mPFC of SHRSP/Ezo as an animal model of attention-deficit/hyperactivity disorder.
J Pharmacol Sci
; 154(2): 61-71, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38246729
19.
Comparison of neuroprotective effects of a topiramate-loaded biocomposite based on mesoporous silica nanoparticles with pure topiramate against methylphenidate-induced neurodegeneration.
Mol Biol Rep
; 51(1): 65, 2024 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38170306
20.
Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial).
Int J Geriatr Psychiatry
; 39(6): e6108, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38858522